High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions.

MLA

Fu, Lin, et al. “High Expression of ETS2 Predicts Poor Prognosis in Acute Myeloid Leukemia and May Guide Treatment Decisions.” Journal of Translational Medicine, vol. 15, no. 1, July 2017, p. 159. EBSCOhost, https://doi.org/10.1186/s12967-017-1260-2.

APA

Fu, L., Fu, H., Wu, Q., Pang, Y., Xu, K., Zhou, L., Qiao, J., Ke, X., Xu, K., & Shi, J. (2017). High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions. Journal of Translational Medicine, 15(1), 159. https://doi.org/10.1186/s12967-017-1260-2

Chicago

Fu, Lin, Huaping Fu, Qingyun Wu, Yifan Pang, Keman Xu, Lei Zhou, Jianlin Qiao, Xiaoyan Ke, Kailin Xu, and Jinlong Shi. 2017. “High Expression of ETS2 Predicts Poor Prognosis in Acute Myeloid Leukemia and May Guide Treatment Decisions.” Journal of Translational Medicine 15 (1): 159. doi:10.1186/s12967-017-1260-2.